Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LANADELUMAB-FLYO vs LANREOTIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LANADELUMAB-FLYO vs LANREOTIDE: Safety Overview

Metric LANADELUMAB-FLYO LANREOTIDE
Total FAERS Reports 1,493 9,007
Deaths Reported 35 1,434
Death Rate 2.3% 15.9%
Hospitalizations 427 2,178
Average Patient Age 45.0 yrs 60.2 yrs
% Female Patients 77.3% 53.8%
FDA Approval Date N/A Aug 30, 2007
Manufacturer N/A Cipla USA Inc.
Route N/A SUBCUTANEOUS
Marketing Status Prescription Prescription